# Automated editorial proposal

- Proposal ID: proposal:67cfea8b8e8b1d39139d43306d4adc41
- Substance: lutein
- Suggestion type: new-effect
- Source: [Lutein inhibits ATF3-mediated PINK1/Parkin signaling to modulate neuronal mitophagy and alleviate Parkinson's disease progression.](https://pubmed.ncbi.nlm.nih.gov/42973181/)
- PMID: 42973181
- DOI: 10.14670/hh-25-167
- Published: 2026-11-03
- Journal: not stated

This file is a review proposal. It is not a published BHWiki article and must not be treated as medical guidance.

## Embedded source snapshot

This abstract snapshot is included so an offline reviewer can check abstract-level claims. It is not a substitute for full-text, version, retraction or licensing verification.

### Abstract

> <h4>Background and purpose</h4>Mitophagy impairment plays a key role in Parkinson's disease (PD) progression. Our previous studies showed that lutein, a carotenoid, alleviates PD by inhibiting neuronal ferroptosis and microglial pro-inflammatory polarization. However, whether lutein regulates mitophagy in PD remains unclear. This study investigates the effects and molecular mechanisms of lutein on mitophagy in PD neuronal cells.<h4>Methods</h4>A PD mouse model was established via intraperitoneal injection of MPTP, and an <i>in vitro</i> PD cell model was constructed using MPP+-induced SH-SY5Y cells. Motor deficits in mice were assessed through behavioral tests; brain tissue pathological changes were observed via HE staining; neuronal damage was evaluated by TH immunohistochemistry; mitochondrial membrane potential and autophagy levels were detected using JC-1 staining, western blot, and transmission electron microscopy, while RT-qPCR and western blot measured the expression of key molecules. ChIP-qPCR was used to examine the binding of ATF3 to the <i>PINK1</i> promoter.<h4>Results</h4>Lutein treatment significantly alleviated MPTP-induced pathological damage in the brain tissue of PD mice, increased the number of TH-positive neurons, and improved motor deficits in PD mice. Additionally, lutein restored mitochondrial membrane potential in MPP<sup>+</sup>-induced neuronal cells, upregulated LC3B, PINK1, and Parkin protein expression, and ameliorated mitophagy dysfunction in neuronal cells. Mechanistically, lutein attenuates MPP<sup>+</sup>-triggered upregulation of ATF3. ATF3 overexpression partially counteracts the regulatory effect of lutein on neuronal mitophagy. Moreover, ATF3 directly binds to the promoter region of <i>PINK1</i> to negatively modulate its transcription. Knockdown of PINK1 reverses the mitophagy activation and neuroprotective effects induced by ATF3 silencing.<h4>Conclusion</h4>Lutein downregulates ATF3, thereby relieving its repression of the PINK1/Parkin signaling pathway and supporting mitochondrial quality control and mitophagy-associated signaling, which slows PD progression.

## Proposed structured change

```json
{
  "effect": "Improves Parkinsonian motor deficits and neuronal pathology in a mouse model of Parkinson's disease.",
  "context": "MPTP-induced Parkinson's disease mouse model"
}
```

## Model rationale

The abstract reports improved motor deficits, reduced pathological damage, and increased TH-positive neurons after lutein treatment in PD mice.

## Verbatim evidence from the abstract

> Lutein treatment significantly alleviated MPTP-induced pathological damage in the brain tissue of PD mice, increased the number of TH-positive neurons, and improved motor deficits in PD mice.

## Human review

- [ ] Open the canonical publication and inspect the strongest permitted full text.
- [ ] Verify article version, retraction/correction state, population, exposure, comparator, outcome and limitations.
- [ ] Verify funding/conflict and reuse rights; remove any unsupported field.
- [ ] Apply changes manually to the appropriate Markdown source; do not edit this proposal into public content.
- [ ] Run `bun run content:validate`, `bun run test`, and the normal publisher before merging.
